Comparison of dexamethasone route of administration on ankle block duration and analgesia for foot and ankle surgery

Phase 4

Recruiting

• Conditions: Foot and ankle analgesia; Anaesthesiology - Pain management

• Registration Number: ACTRN12611001166965
• Lead Sponsor: Ms Rachel Dawson

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-11-08
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Elective patients having metatarsal osteotomy for foot surgery

American Society of Anaesthesiologists score 1-3

Exclusion Criteria

American Society of Anaesthesiologists score of 4 or greater

Contraindication to ankle block (patient refusal, coagulopathy, sepsis, local infection, allergy to ropivacaine)

Contraindication to dexamethasone (eg. known hypersensitivity, poorly controlled diabetes mellitus)

Pre-existing sensory deficit around the site of surgical intervention (eg. peripheral neuropathy, stroke)

Systemic glucocorticoid treatment of >10mg prednisolone (or equivalent) for two weeks or more within three months of surgery

Chronic opioid use define as >30mg oral morphine per day or equivalent (Fentanyl patch 12mcg/hr; buprenorphine 20mcg/hr; oxycodone >20mg/day)

Contraindication to non-steroidal anti-inflammatory drugs (NSAIDs) (eg. known hypersensitivity, active peptic ulcer disease, renal impairment, pregnancy)

Previous enrolment in this study

Inability to understand english

Study & Design

• Study Type: Interventional
• Study Design: Not specified